These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

733 related items for PubMed ID: 16356784

  • 1. Pharmacogenetics of antihypertensive treatment.
    Arnett DK, Claas SA, Glasser SP.
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [Abstract] [Full Text] [Related]

  • 2. Blood pressure reduction is not the only determinant of outcome.
    Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR, Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR.
    Circulation; 2006 Jun 13; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract] [Full Text] [Related]

  • 3. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
    Schelleman H, Klungel OH, van Duijn CM, Witteman JC, Hofman A, de Boer A, Stricker BH.
    Ann Pharmacother; 2006 Feb 13; 40(2):212-8. PubMed ID: 16449550
    [Abstract] [Full Text] [Related]

  • 4. Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension.
    Hannila-Handelberg T, Kontula KK, Paukku K, Lehtonen JY, Virtamo J, Tikkanen I, Hiltunen TP.
    J Hypertens; 2010 Apr 13; 28(4):771-9. PubMed ID: 20027122
    [Abstract] [Full Text] [Related]

  • 5. [Hypertension 2007-2008].
    Chatzikyrkou C, Menne J, Haller H.
    Med Klin (Munich); 2009 Aug 13; 104(8):614-21. PubMed ID: 19701732
    [Abstract] [Full Text] [Related]

  • 6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 13; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 7. Renin-angiotensin gene polymorphisms and neurohormonal inhibition.
    Pauly DF.
    Heart Fail Clin; 2010 Jan 13; 6(1):25-6. PubMed ID: 19945057
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive drugs and fibrinolytic function.
    Fogari R, Zoppi A.
    Am J Hypertens; 2006 Dec 13; 19(12):1293-9. PubMed ID: 17161777
    [Abstract] [Full Text] [Related]

  • 9. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects.
    Katragadda S, Arora RR.
    Am J Ther; 2010 Dec 13; 17(1):e11-23. PubMed ID: 20090429
    [Abstract] [Full Text] [Related]

  • 10. Treatment of hypertension.
    Cuddy ML.
    J Pract Nurs; 2006 Dec 13; 56(1):11-5; quiz 18-9. PubMed ID: 16704189
    [No Abstract] [Full Text] [Related]

  • 11. Interactions between five candidate genes and antihypertensive drug therapy on blood pressure.
    Schelleman H, Stricker BH, Verschuren WM, de Boer A, Kroon AA, de Leeuw PW, Kromhout D, Klungel OH.
    Pharmacogenomics J; 2006 Dec 13; 6(1):22-6. PubMed ID: 16314886
    [Abstract] [Full Text] [Related]

  • 12. Clinical and molecular approaches to individualize antihypertensive drug therapy.
    Hiltunen TP, Kontula K.
    Ann Med; 2012 Jun 13; 44 Suppl 1():S23-9. PubMed ID: 22713145
    [Abstract] [Full Text] [Related]

  • 13. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H, Gilbert RE.
    J Hypertens; 2007 Jan 13; 25(1):25-35. PubMed ID: 17143168
    [Abstract] [Full Text] [Related]

  • 14. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P.
    Vnitr Lek; 2006 Sep 13; 52(9):791-6. PubMed ID: 17091602
    [Abstract] [Full Text] [Related]

  • 15. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A, Armigliato M, Zamboni S, Rempelou P, Rubello D, Pessina AC, Casiglia E.
    Minerva Endocrinol; 2008 Dec 13; 33(4):297-312. PubMed ID: 18923367
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacotherapy of hypertension].
    Thürmann PA.
    Z Arztl Fortbild Qualitatssich; 2001 Jun 13; 95(5):345-8. PubMed ID: 11486498
    [Abstract] [Full Text] [Related]

  • 17. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.
    Höcht C, Bertera FM, Mayer MA, Taira CA.
    Expert Opin Drug Metab Toxicol; 2010 Feb 13; 6(2):199-211. PubMed ID: 20095790
    [Abstract] [Full Text] [Related]

  • 18. Selecting antihypertensive medication in patients with essential hypertension in Malaysia.
    Ong HT, Rozina G.
    Med J Malaysia; 2009 Mar 13; 64(1):3-11. PubMed ID: 19852313
    [No Abstract] [Full Text] [Related]

  • 19. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.
    Hypertens Res; 2006 Mar 13; 29(3):143-51. PubMed ID: 16755149
    [Abstract] [Full Text] [Related]

  • 20. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP, Tepel M.
    Minerva Med; 2005 Aug 13; 96(4):277-85. PubMed ID: 16179894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.